In despite of contradictory clinical results, researchers found that GPNMB was both transcriptionally and expressively elevated in the substantia nigra areas of PD patients (Murthy et al., 2017; Moloney et al., 2018; Neal et al., 2018). The gene discussed is GPNMB; the disease is Parkinson disease.